搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Streptococcus equi subsp. zooepidemicus Uracil phosphoribosyltransferase (upp) CSB-YP472923FMK
CSB-EP472923FMK
CSB-BP472923FMK
CSB-MP472923FMK
CSB-EP472923FMK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. zooepidemicus Serine/threonine transporter sstT (sstT), partial CSB-YP472924FMK
CSB-EP472924FMK
CSB-BP472924FMK
CSB-MP472924FMK
CSB-EP472924FMK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. zooepidemicus 30S ribosomal protein S10 (rpsJ) CSB-YP472925FMK
CSB-EP472925FMK
CSB-BP472925FMK
CSB-MP472925FMK
CSB-EP472925FMK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. zooepidemicus 50S ribosomal protein L14 (rplN) CSB-YP472926FMK
CSB-EP472926FMK
CSB-BP472926FMK
CSB-MP472926FMK
CSB-EP472926FMK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. zooepidemicus Cysteine--tRNA ligase (cysS) CSB-YP472927FMK
CSB-EP472927FMK
CSB-BP472927FMK
CSB-MP472927FMK
CSB-EP472927FMK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. zooepidemicus Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP472928FMK
CSB-EP472928FMK
CSB-BP472928FMK
CSB-MP472928FMK
CSB-EP472928FMK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. Bifunctional protein GlmU (glmU) CSB-YP472929HXT
CSB-EP472929HXT
CSB-BP472929HXT
CSB-MP472929HXT
CSB-EP472929HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. Ribosome maturation factor RimP (rimP) CSB-YP472930HXT
CSB-EP472930HXT
CSB-BP472930HXT
CSB-MP472930HXT
CSB-EP472930HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. 50S ribosomal protein L7/L12 (rplL) CSB-YP472931HXT
CSB-EP472931HXT
CSB-BP472931HXT
CSB-MP472931HXT
CSB-EP472931HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. 50S ribosomal protein L3 (rplC) CSB-YP472932HXT
CSB-EP472932HXT
CSB-BP472932HXT
CSB-MP472932HXT
CSB-EP472932HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. 50S ribosomal protein L22 (rplV) CSB-YP472933HXT
CSB-EP472933HXT
CSB-BP472933HXT
CSB-MP472933HXT
CSB-EP472933HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. 50S ribosomal protein L6 (rplF) CSB-YP472934HXT
CSB-EP472934HXT
CSB-BP472934HXT
CSB-MP472934HXT
CSB-EP472934HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. 50S ribosomal protein L36 (rpmJ) CSB-YP472935HXT
CSB-EP472935HXT
CSB-BP472935HXT
CSB-MP472935HXT
CSB-EP472935HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. Serine--tRNA ligase (serS) CSB-YP472936HXT
CSB-EP472936HXT
CSB-BP472936HXT
CSB-MP472936HXT
CSB-EP472936HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. Aspartate--tRNA ligase (aspS), partial CSB-YP472937HXT
CSB-EP472937HXT
CSB-BP472937HXT
CSB-MP472937HXT
CSB-EP472937HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. ATP-dependent zinc metalloprotease FtsH (ftsH), partial CSB-YP472938HXT
CSB-EP472938HXT
CSB-BP472938HXT
CSB-MP472938HXT
CSB-EP472938HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. Proline--tRNA ligase (proS), partial CSB-YP472939HXT
CSB-EP472939HXT
CSB-BP472939HXT
CSB-MP472939HXT
CSB-EP472939HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. Aspartate 1-decarboxylase (panD) CSB-YP472940HXT
CSB-EP472940HXT
CSB-BP472940HXT
CSB-MP472940HXT
CSB-EP472940HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP472941HXT
CSB-EP472941HXT
CSB-BP472941HXT
CSB-MP472941HXT
CSB-EP472941HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hydrogenobaculum sp. 50S ribosomal protein L25 (rplY) CSB-YP472942HXT
CSB-EP472942HXT
CSB-BP472942HXT
CSB-MP472942HXT
CSB-EP472942HXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>